Correction to: Pediatric and adult patients with ME/CFS following COVID-19: A structured approach to diagnosis using the Munich Berlin Symptom Questionnaire (MBSQ)

Full text

Vol.:(0123456789)
European Journal of Pediatrics (2025) 184:302
https://doi.org/10.1007/s00431-025-06112-w
CORRECTION
Correction to: Pediatric andadult patients withME/CFS
followingCOVID‑19: Astructured approach todiagnosis using
theMunich Berlin Symptom Questionnaire (MBSQ)
Laura‑CarlottaPeo1· KatharinaWiehler1· JohannesPaulick1· KatrinGerrer1· ArianeLeone1· AnjaViereck1·
MatthiasHaegele1· SilviaStojanov2· CordulaWarlitz1· SilviaAugustin1· MartinAlberer1· DanielB.R.Hattesohl3·
LauraFroehlich4· CarmenScheibenbogen5· LeonardA.Jason6· LorenzL.Mihatsch1· RafaelPricoco1,5·
UtaBehrends1,7
Published online: 17 April 2025
© The Author(s) 2025
Laura-Carlotta Peo, Katharina Wiehler, Rafael Pricoco, and Uta
Behrends contributed equally to this work.
The original article can be found online at https:// doi. org/ 10. 1007/
s00431- 023- 05351-z.
* Uta Behrends
uta.behrends@mri.tum.de
1 MRI Chronic Fatigue Center forYoung People (MCFC),
Pediatrics, Children’S Hospital, TUM School ofMedicine,
Technical University ofMunich, Munich, Germany
2 MRI Chronic Fatigue Center forYoung People (MCFC),
Child andAdolescent Psychsomatics, Children’S Hospital,
TUM School ofMedicine, Technical University ofMunich,
Munich, Germany
3 German Association forME/CFS, Hamburg, Germany
4 Research Center CATALPA, FernUniversität inHagen,
Hagen, Germany
5 Institute ofMedical Immunology, Charité
- Universitätsmedizin Berlin, Corporate Member ofFreie
Universität Berlin andHumboldt Universität Zu Berlin
andBerlin Institute ofHealth (BIH), Berlin, Germany
6 Center forCommunity Research, Depaul University,
Chicago, IL60614, USA
7 German Center forInfection Research (DZIF), Munich,
Germany
Correction to: European Journal of Pediatrics (2023) 183:1265–1276
https://doi.org/10.1007/s00431-023-05351-z
In the originally published article, entitled “Pediatric and
adult patients with ME/CFS following COVID-19: A struc-
tured approach to diagnosis using the Munich Berlin Symp-
tom Questionnaire (MBSQ)”, the Supplementary Scoring
Sheets to the MBSQ, which are contained in the Supplemen-
tary File 1 (English version) and Supplementary File 2 (Ger-
man version), contain an error. The dimension “Sleep, Pain,
and Neurocognitive Symptoms” was incorrectly adopted for
pediatric and adolescent patients from the Clinical Diagnos-
tic Worksheet of Rowe, PC etal. (2017) [1].
Published version:
Supplementary File 1 – English Version for Pediatric and
Adolescent Patients, page 2 of the Supplementary Scoring
Sheet to the MBSQ.
Clinical Diagnostic Worksheet by Rowe PC etal.2
Sleep, Pain, and Neurocognitive Symptoms
At least 2 of the following 3 categories must apply
□ At least 1 of the following 5 points must apply:
III.13–17 ≥ 2
□ At least 1 of the following 6 points must apply: IV.18–21,
V.22–43 ≥ 2
□ At least 1 of the following 8 points must apply: V.23–25,
V.27–28, V.30, V.33 ≥ 2; V.29: Yes
Supplementary File 2 – German Version for Pediatric and
Adolescent Patients, page 2 of the Supplementary Scoring
Sheet to the MBSQ.
Clinical Diagnostic Worksheet by Rowe PC etal.2
Schlaf, Schmerz und neurokognitive Symptome
Mind. 2 der 3 Kategorien müssen erfüllt sein:
□ mind. 1 der nachfolgenden 5 Punkte muss erfüllt sein:
III.13–17 ≥ 2
Content courtesy of Springer Nature, terms of use apply. Rights reserved.

European Journal of Pediatrics (2025) 184:302302 Page 2 of 2
□ mind. 1 der nachfolgenden 6 Punkte muss erfüllt sein:
IV.18–21, V.22–43 ≥ 2
□ mind. 1 der nachfolgenden 8 Punkte muss erfüllt sein:
V.23–25, V.27–28, V.30, V.33 ≥ 2; V.29: Ja
Corrected version:
Supplementary File 1 – English Version for Pediatric and
Adolescent Patients, page 2 of the Supplementary Scoring
Sheet to the MBSQ.
Clinical Diagnostic Worksheet by Rowe PC etal.2
Sleep, Pain, and Neurocognitive Symptoms
At least 2 of the following 3 categories must apply.
□ At least 1 of the following 5 points must apply:
III.13–17 ≥ 2
□ At least 1 of the following 6 points must apply: IV.18–21,
VIII.57, VIII.59 ≥ 2
□ At least 1 of the following 8 points must apply: V.23–25,
V.27–28, V.30, V.33 ≥ 2; V.29: Yes
Supplementary File 2 – German Version for Pediatric and
Adolescent Patients, page 2 of the Supplementary Scoring
Sheet to the MBSQ.
Clinical Diagnostic Worksheet by Rowe PC etal.2
Schlaf, Schmerz und neurokognitive Symptome
Mind. 2 der 3 Kategorien müssen erfüllt sein:
□ mind. 1 der nachfolgenden 5 Punkte muss erfüllt sein:
III.13–17 ≥ 2
□ mind. 1 der nachfolgenden 6 Punkte muss erfüllt sein:
IV.18–21, VIII.57, VIII.59 ≥ 2
□ mind. 1 der nachfolgenden 8 Punkte muss erfüllt sein:
V.23–25, V.27–28, V.30, V.33 ≥ 2; V.29: Ja
The original article has been corrected, and Supplementary
File 1 and Supplementary File 2 have been replaced with the
corrected versions.
Open Access This article is licensed under a Creative Commons Attri-
bution 4.0 International License, which permits use, sharing, adapta-
tion, distribution and reproduction in any medium or format, as long
as you give appropriate credit to the original author(s) and the source,
provide a link to the Creative Commons licence, and indicate if changes
were made. The images or other third party material in this article are
included in the article's Creative Commons licence, unless indicated
otherwise in a credit line to the material. If material is not included in
the article's Creative Commons licence and your intended use is not
permitted by statutory regulation or exceeds the permitted use, you will
need to obtain permission directly from the copyright holder. To view a
copy of this licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/.
References
1. Rowe PC, Underhill RA, Friedman KJ etal (2017) Myalgic
encephalomyelitis/chronic fatigue syndrome diagnosis and man-
agement in young people: a primer. Front Pediatr 5:121. https://
doi. org/ 10. 3389/ fped. 2017. 00121
Publisher's Note Springer Nature remains neutral with regard to
jurisdictional claims in published maps and institutional affiliations.
Content courtesy of Springer Nature, terms of use apply. Rights reserved.

1.
2.
3.
4.
5.
6.
Terms and Conditions
Springer Nature journal content, brought to you courtesy of Springer Nature Customer Service Center GmbH (“Springer Nature”).
Springer Nature supports a reasonable amount of sharing of research papers by authors, subscribers and authorised users (“Users”), for small-
scale personal, non-commercial use provided that all copyright, trade and service marks and other proprietary notices are maintained. By
accessing, sharing, receiving or otherwise using the Springer Nature journal content you agree to these terms of use (“Terms”). For these
purposes, Springer Nature considers academic use (by researchers and students) to be non-commercial.
These Terms are supplementary and will apply in addition to any applicable website terms and conditions, a relevant site licence or a personal
subscription. These Terms will prevail over any conflict or ambiguity with regards to the relevant terms, a site licence or a personal subscription
(to the extent of the conflict or ambiguity only). For Creative Commons-licensed articles, the terms of the Creative Commons license used will
apply.
We collect and use personal data to provide access to the Springer Nature journal content. We may also use these personal data internally within
ResearchGate and Springer Nature and as agreed share it, in an anonymised way, for purposes of tracking, analysis and reporting. We will not
otherwise disclose your personal data outside the ResearchGate or the Springer Nature group of companies unless we have your permission as
detailed in the Privacy Policy.
While Users may use the Springer Nature journal content for small scale, personal non-commercial use, it is important to note that Users may
not:
use such content for the purpose of providing other users with access on a regular or large scale basis or as a means to circumvent access
control;
use such content where to do so would be considered a criminal or statutory offence in any jurisdiction, or gives rise to civil liability, or is
otherwise unlawful;
falsely or misleadingly imply or suggest endorsement, approval , sponsorship, or association unless explicitly agreed to by Springer Nature in
writing;
use bots or other automated methods to access the content or redirect messages
override any security feature or exclusionary protocol; or
share the content in order to create substitute for Springer Nature products or services or a systematic database of Springer Nature journal
content.
In line with the restriction against commercial use, Springer Nature does not permit the creation of a product or service that creates revenue,
royalties, rent or income from our content or its inclusion as part of a paid for service or for other commercial gain. Springer Nature journal
content cannot be used for inter-library loans and librarians may not upload Springer Nature journal content on a large scale into their, or any
other, institutional repository.
These terms of use are reviewed regularly and may be amended at any time. Springer Nature is not obligated to publish any information or
content on this website and may remove it or features or functionality at our sole discretion, at any time with or without notice. Springer Nature
may revoke this licence to you at any time and remove access to any copies of the Springer Nature journal content which have been saved.
To the fullest extent permitted by law, Springer Nature makes no warranties, representations or guarantees to Users, either express or implied
with respect to the Springer nature journal content and all parties disclaim and waive any implied warranties or warranties imposed by law,
including merchantability or fitness for any particular purpose.
Please note that these rights do not automatically extend to content, data or other material published by Springer Nature that may be licensed
from third parties.
If you would like to use or distribute our Springer Nature journal content to a wider audience or on a regular basis or in any other manner not
expressly permitted by these Terms, please contact Springer Nature at
onlineservice@springernature.com